NCT02838316View on ClinicalTrials.gov

Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Oropharyngeal Dysphagia
Interventions
DRUG

Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)

Autologous muscle derived stem cells

Trial Locations (1)

95817

UC Davis Medical Center, Department of Otolaryngology, Head and Neck Surgery, Sacramento

Sponsors

Collaborators (1)

Cook MyoSite
All Listed Sponsors
collaborator

Cook MyoSite

INDUSTRY

lead

Peter Belafsky, MD

OTHER